Individuals Stopping Anti-Obesity Injections Gain Back Pounds Far More Rapidly Compared to Dieters

A recent study reveals that individuals who stop using blockbuster slimming jabs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who halt conventional lifestyle regimens.

Research printed in a major health publication shows that while overweight individuals often shed substantial amounts of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month after stopping.

"Users buying such medications need to be aware of the danger of rapid rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.

Such speed of recovery suggests a return to pre-treatment mass in about a year and a half.

Comparing Treatments

The analysis, which examined dozens of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with older methods.

Scientists emphasize that individuals who lose weight through lifestyle changes alone usually have a less rapid weight regain—perhaps 0.1 kg a month—post-intervention.

Explaining the Quick Rebound

Experts believe the mechanism of the jabs accounts for the amplified regain.

These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.

"Long-term administration of the hormone levels several times higher than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating a significant risk."

An Ongoing Issue?

The NHS suggest the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Many experts argue that, due to the likelihood of weight regain, the therapy might need to be ongoing.

This view is reinforced by drug manufacturers, who say that the results "highlight the chronic nature of excess weight," similar to managing conditions like hypertension.

User Testimonies

People who have discontinued the medication describe a intense resurgence of hunger.

"I experienced something activating and I was suddenly starving," recalled a patient.

This difficulty is compounded if patients have not developed sustainable lifestyle or habit changes during therapy.

Widespread Adoption

Figures indicate that a significant number of people in the UK have tried these injections in the last 12 months, with demand continuing to grow.

• Adoption is greater among females compared to males.
• The middle-aged age group shows the highest level of interest.
• Many obtain the medications through private prescriptions rather than the NHS.

Finally, experts stress that while these medications are potent tools for weight loss, they are not a magic solution and maintained weight loss likely depends on integrated behavioural changes.